View Future GrowthSpolytech 과거 순이익 실적과거 기준 점검 0/6Spolytech 의 수입은 연평균 -45.5%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 1.1%의 비율로 증가했습니다. 매출은 연평균 13.9%의 비율로 감소해 왔습니다.핵심 정보-45.54%순이익 성장률-45.59%주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률-13.90%자기자본이익률-15.59%순이익률-13.17%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트분석 기사 • Mar 25Spolytech's (KOSDAQ:050760) Solid Profits Have Weak FundamentalsSpolytech Co., Ltd. ( KOSDAQ:050760 ) announced strong profits, but the stock was stagnant. We did some digging, and we...Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩325 (vs ₩355 loss in FY 2023)Full year 2024 results: EPS: ₩325 (up from ₩355 loss in FY 2023). Revenue: ₩80.2b (up 9.5% from FY 2023). Net income: ₩5.03b (up ₩10.5b from FY 2023). Profit margin: 6.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩88.00 (vs ₩7.00 in 1Q 2023)First quarter 2024 results: EPS: ₩88.00 (up from ₩7.00 in 1Q 2023). Revenue: ₩17.9b (up 3.6% from 1Q 2023). Net income: ₩1.36b (up ₩1.25b from 1Q 2023). Profit margin: 7.6% (up from 0.6% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 26Full year 2023 earnings released: ₩355 loss per share (vs ₩183 loss in FY 2022)Full year 2023 results: ₩355 loss per share (further deteriorated from ₩183 loss in FY 2022). Revenue: ₩73.2b (down 11% from FY 2022). Net loss: ₩5.48b (loss widened 94% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩30.00 (vs ₩127 in 3Q 2022)Third quarter 2023 results: EPS: ₩30.00 (down from ₩127 in 3Q 2022). Revenue: ₩17.5b (down 2.9% from 3Q 2022). Net income: ₩463.9m (down 76% from 3Q 2022). Profit margin: 2.6% (down from 11% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩7.00 (vs ₩72.00 in 1Q 2022)First quarter 2023 results: EPS: ₩7.00 (down from ₩72.00 in 1Q 2022). Revenue: ₩17.2b (down 33% from 1Q 2022). Net income: ₩103.7m (down 91% from 1Q 2022). Profit margin: 0.6% (down from 4.3% in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updates공시 • Mar 04Spolytech Co., Ltd., Annual General Meeting, Mar 31, 2026Spolytech Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 275, hansam-ro, deoksan-myeon, jincheon-gun, chungcheongbuk-do, South Korea분석 기사 • Nov 05Spolytech Co., Ltd. (KOSDAQ:050760) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Korea, you could be...분석 기사 • Jul 16Spolytech (KOSDAQ:050760) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Apr 20New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.4% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 57% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩28.4b market cap, or US$20.0m).분석 기사 • Mar 25Spolytech's (KOSDAQ:050760) Solid Profits Have Weak FundamentalsSpolytech Co., Ltd. ( KOSDAQ:050760 ) announced strong profits, but the stock was stagnant. We did some digging, and we...Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩325 (vs ₩355 loss in FY 2023)Full year 2024 results: EPS: ₩325 (up from ₩355 loss in FY 2023). Revenue: ₩80.2b (up 9.5% from FY 2023). Net income: ₩5.03b (up ₩10.5b from FY 2023). Profit margin: 6.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.공시 • Feb 28Spolytech Co., Ltd., Annual General Meeting, Mar 26, 2025Spolytech Co., Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 275, hansam-ro, deoksan-myeon, jincheon-gun, chungcheongbuk-do, South Korea분석 기사 • Jan 17We Think Spolytech (KOSDAQ:050760) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Nov 13Risks To Shareholder Returns Are Elevated At These Prices For Spolytech Co., Ltd. (KOSDAQ:050760)It's not a stretch to say that Spolytech Co., Ltd.'s ( KOSDAQ:050760 ) price-to-sales (or "P/S") ratio of 0.3x right...Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩88.00 (vs ₩7.00 in 1Q 2023)First quarter 2024 results: EPS: ₩88.00 (up from ₩7.00 in 1Q 2023). Revenue: ₩17.9b (up 3.6% from 1Q 2023). Net income: ₩1.36b (up ₩1.25b from 1Q 2023). Profit margin: 7.6% (up from 0.6% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 26Full year 2023 earnings released: ₩355 loss per share (vs ₩183 loss in FY 2022)Full year 2023 results: ₩355 loss per share (further deteriorated from ₩183 loss in FY 2022). Revenue: ₩73.2b (down 11% from FY 2022). Net loss: ₩5.48b (loss widened 94% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩30.00 (vs ₩127 in 3Q 2022)Third quarter 2023 results: EPS: ₩30.00 (down from ₩127 in 3Q 2022). Revenue: ₩17.5b (down 2.9% from 3Q 2022). Net income: ₩463.9m (down 76% from 3Q 2022). Profit margin: 2.6% (down from 11% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.New Risk • Nov 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₩38.2b market cap, or US$29.6m).Buying Opportunity • Aug 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩2,606, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩7.00 (vs ₩72.00 in 1Q 2022)First quarter 2023 results: EPS: ₩7.00 (down from ₩72.00 in 1Q 2022). Revenue: ₩17.2b (down 33% from 1Q 2022). Net income: ₩103.7m (down 91% from 1Q 2022). Profit margin: 0.6% (down from 4.3% in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.Upcoming Dividend • Dec 21Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 13 April 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Reported Earnings • Nov 20Third quarter 2022 earnings released: EPS: ₩121 (vs ₩123 in 3Q 2021)Third quarter 2022 results: EPS: ₩121 (down from ₩123 in 3Q 2021). Revenue: ₩18.0b (down 32% from 3Q 2021). Net income: ₩1.87b (down 1.4% from 3Q 2021). Profit margin: 10% (up from 7.2% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Buying Opportunity • Oct 26Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be ₩3,225, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.Buying Opportunity • Oct 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be ₩3,288, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,690, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 24% over the past three years.Buying Opportunity • Sep 23Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 4.5%. The fair value is estimated to be ₩3,753, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩3,835, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past three years.Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₩4,610, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩4,055, the stock trades at a trailing P/E ratio of 8.6x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 107% over the past three years.분석 기사 • May 05Key Things To Consider Before Buying Spolytech Co., Ltd. (KOSDAQ:050760) For Its DividendIs Spolytech Co., Ltd. ( KOSDAQ:050760 ) a good dividend stock? How can we tell? Dividend paying companies with growing...분석 기사 • Mar 23Spolytech (KOSDAQ:050760) Seems To Use Debt Quite SensiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Mar 08New 90-day low: ₩5,250The company is down 11% from its price of ₩5,870 on 08 December 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.분석 기사 • Mar 02Spolytech Co., Ltd.'s (KOSDAQ:050760) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?With its stock down 12% over the past three months, it is easy to disregard Spolytech (KOSDAQ:050760). However, stock...분석 기사 • Feb 04Why Spolytech Co., Ltd. (KOSDAQ:050760) Should Be In Your Dividend PortfolioIs Spolytech Co., Ltd. ( KOSDAQ:050760 ) a good dividend stock? How can we tell? Dividend paying companies with growing...분석 기사 • Jan 14Did You Participate In Any Of Spolytech's (KOSDAQ:050760) Fantastic 298% Return ?While Spolytech Co., Ltd. ( KOSDAQ:050760 ) shareholders are probably generally happy, the stock hasn't had...Is New 90 Day High Low • Jan 13New 90-day low: ₩5,430The company is down 30% from its price of ₩7,750 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 34% over the same period.분석 기사 • Dec 24Spolytech Co., Ltd. (KOSDAQ:050760) Passed Our Checks, And It's About To Pay A ₩50.00 DividendSpolytech Co., Ltd. ( KOSDAQ:050760 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...분석 기사 • Dec 23Is Spolytech (KOSDAQ:050760) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 14th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.9% is below the top quartile of South Korean dividend payers (2.6%), but is in line with industry peers (0.9%).Is New 90 Day High Low • Dec 21New 90-day low: ₩5,740The company is down 22% from its price of ₩7,380 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.분석 기사 • Dec 02Is Weakness In Spolytech Co., Ltd. (KOSDAQ:050760) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Spolytech (KOSDAQ:050760) has had a rough three months with its share price down 23%. But if you pay close attention...Is New 90 Day High Low • Nov 24New 90-day low: ₩6,420The company is down 14% from its price of ₩7,430 on 27 August 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.매출 및 비용 세부 내역Spolytech가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A050760 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 2566,755-8,79210,75276630 Sep 2573,970-41610,48875830 Jun 2575,384-1,99010,37182431 Mar 2578,1842,29410,67280131 Dec 2480,1635,02510,63370130 Sep 2476,016-4,93410,50478530 Jun 2475,412-2,58810,41480631 Mar 2473,842-4,22210,42480131 Dec 2373,218-5,47610,86486130 Sep 2372,264-7,37611,15984430 Jun 2372,794-5,88611,25279931 Mar 2374,018-3,82411,28684231 Dec 2282,460-2,82811,33181330 Sep 2289,4914,20211,67383030 Jun 2297,8334,14711,92981931 Mar 22105,8713,29911,91374731 Dec 21109,7645,32711,27873430 Sep 21113,9123,12711,53871030 Jun 21128,2334,91213,58877531 Mar 21137,2487,28915,35595731 Dec 20135,2437,72415,5121,09330 Sep 20135,56211,74815,1551,14430 Jun 20129,27911,64813,0591,08431 Mar 20127,95311,74511,17388931 Dec 19135,03310,74310,95670530 Sep 19143,37412,29810,59462030 Jun 19142,4958,34010,49666531 Mar 19141,7274,38111,01976131 Dec 18136,8871,51311,31783330 Sep 18128,803-4,02511,33277830 Jun 18126,352-3,71211,79977031 Mar 18121,770-2,98311,82675231 Dec 17122,283-3,05611,95978930 Sep 17124,1681,64612,39692430 Jun 17124,8172,79912,14097231 Mar 17123,4913,51811,62392431 Dec 16117,6973,93811,29691530 Sep 16111,2691,79610,87786430 Jun 16106,2501,04411,10276731 Mar 16101,808-14511,76083931 Dec 15100,317-1,71512,06295130 Sep 15102,326-4,61113,08098530 Jun 15101,550-5,12712,6271,099양질의 수익: A050760 은(는) 현재 수익성이 없습니다.이익 마진 증가: A050760는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A050760은 수익성이 없으며 지난 5년 동안 손실이 연평균 45.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A050760의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A050760은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-3.4%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A050760는 현재 수익성이 없으므로 자본 수익률이 음수(-15.59%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/18 07:27종가2026/05/15 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Spolytech Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
분석 기사 • Mar 25Spolytech's (KOSDAQ:050760) Solid Profits Have Weak FundamentalsSpolytech Co., Ltd. ( KOSDAQ:050760 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩325 (vs ₩355 loss in FY 2023)Full year 2024 results: EPS: ₩325 (up from ₩355 loss in FY 2023). Revenue: ₩80.2b (up 9.5% from FY 2023). Net income: ₩5.03b (up ₩10.5b from FY 2023). Profit margin: 6.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩88.00 (vs ₩7.00 in 1Q 2023)First quarter 2024 results: EPS: ₩88.00 (up from ₩7.00 in 1Q 2023). Revenue: ₩17.9b (up 3.6% from 1Q 2023). Net income: ₩1.36b (up ₩1.25b from 1Q 2023). Profit margin: 7.6% (up from 0.6% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 26Full year 2023 earnings released: ₩355 loss per share (vs ₩183 loss in FY 2022)Full year 2023 results: ₩355 loss per share (further deteriorated from ₩183 loss in FY 2022). Revenue: ₩73.2b (down 11% from FY 2022). Net loss: ₩5.48b (loss widened 94% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩30.00 (vs ₩127 in 3Q 2022)Third quarter 2023 results: EPS: ₩30.00 (down from ₩127 in 3Q 2022). Revenue: ₩17.5b (down 2.9% from 3Q 2022). Net income: ₩463.9m (down 76% from 3Q 2022). Profit margin: 2.6% (down from 11% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩7.00 (vs ₩72.00 in 1Q 2022)First quarter 2023 results: EPS: ₩7.00 (down from ₩72.00 in 1Q 2022). Revenue: ₩17.2b (down 33% from 1Q 2022). Net income: ₩103.7m (down 91% from 1Q 2022). Profit margin: 0.6% (down from 4.3% in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
공시 • Mar 04Spolytech Co., Ltd., Annual General Meeting, Mar 31, 2026Spolytech Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 275, hansam-ro, deoksan-myeon, jincheon-gun, chungcheongbuk-do, South Korea
분석 기사 • Nov 05Spolytech Co., Ltd. (KOSDAQ:050760) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Korea, you could be...
분석 기사 • Jul 16Spolytech (KOSDAQ:050760) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Apr 20New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.4% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 57% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩28.4b market cap, or US$20.0m).
분석 기사 • Mar 25Spolytech's (KOSDAQ:050760) Solid Profits Have Weak FundamentalsSpolytech Co., Ltd. ( KOSDAQ:050760 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩325 (vs ₩355 loss in FY 2023)Full year 2024 results: EPS: ₩325 (up from ₩355 loss in FY 2023). Revenue: ₩80.2b (up 9.5% from FY 2023). Net income: ₩5.03b (up ₩10.5b from FY 2023). Profit margin: 6.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
공시 • Feb 28Spolytech Co., Ltd., Annual General Meeting, Mar 26, 2025Spolytech Co., Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 275, hansam-ro, deoksan-myeon, jincheon-gun, chungcheongbuk-do, South Korea
분석 기사 • Jan 17We Think Spolytech (KOSDAQ:050760) Has A Fair Chunk Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Nov 13Risks To Shareholder Returns Are Elevated At These Prices For Spolytech Co., Ltd. (KOSDAQ:050760)It's not a stretch to say that Spolytech Co., Ltd.'s ( KOSDAQ:050760 ) price-to-sales (or "P/S") ratio of 0.3x right...
Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩88.00 (vs ₩7.00 in 1Q 2023)First quarter 2024 results: EPS: ₩88.00 (up from ₩7.00 in 1Q 2023). Revenue: ₩17.9b (up 3.6% from 1Q 2023). Net income: ₩1.36b (up ₩1.25b from 1Q 2023). Profit margin: 7.6% (up from 0.6% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 26Full year 2023 earnings released: ₩355 loss per share (vs ₩183 loss in FY 2022)Full year 2023 results: ₩355 loss per share (further deteriorated from ₩183 loss in FY 2022). Revenue: ₩73.2b (down 11% from FY 2022). Net loss: ₩5.48b (loss widened 94% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩30.00 (vs ₩127 in 3Q 2022)Third quarter 2023 results: EPS: ₩30.00 (down from ₩127 in 3Q 2022). Revenue: ₩17.5b (down 2.9% from 3Q 2022). Net income: ₩463.9m (down 76% from 3Q 2022). Profit margin: 2.6% (down from 11% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
New Risk • Nov 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₩38.2b market cap, or US$29.6m).
Buying Opportunity • Aug 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩2,606, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩7.00 (vs ₩72.00 in 1Q 2022)First quarter 2023 results: EPS: ₩7.00 (down from ₩72.00 in 1Q 2022). Revenue: ₩17.2b (down 33% from 1Q 2022). Net income: ₩103.7m (down 91% from 1Q 2022). Profit margin: 0.6% (down from 4.3% in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • Dec 21Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 13 April 2023. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Reported Earnings • Nov 20Third quarter 2022 earnings released: EPS: ₩121 (vs ₩123 in 3Q 2021)Third quarter 2022 results: EPS: ₩121 (down from ₩123 in 3Q 2021). Revenue: ₩18.0b (down 32% from 3Q 2021). Net income: ₩1.87b (down 1.4% from 3Q 2021). Profit margin: 10% (up from 7.2% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Buying Opportunity • Oct 26Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be ₩3,225, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.
Buying Opportunity • Oct 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be ₩3,288, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.
Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,690, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 24% over the past three years.
Buying Opportunity • Sep 23Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 4.5%. The fair value is estimated to be ₩3,753, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 38%.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩3,835, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past three years.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₩4,610, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩4,055, the stock trades at a trailing P/E ratio of 8.6x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 107% over the past three years.
분석 기사 • May 05Key Things To Consider Before Buying Spolytech Co., Ltd. (KOSDAQ:050760) For Its DividendIs Spolytech Co., Ltd. ( KOSDAQ:050760 ) a good dividend stock? How can we tell? Dividend paying companies with growing...
분석 기사 • Mar 23Spolytech (KOSDAQ:050760) Seems To Use Debt Quite SensiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Mar 08New 90-day low: ₩5,250The company is down 11% from its price of ₩5,870 on 08 December 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
분석 기사 • Mar 02Spolytech Co., Ltd.'s (KOSDAQ:050760) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?With its stock down 12% over the past three months, it is easy to disregard Spolytech (KOSDAQ:050760). However, stock...
분석 기사 • Feb 04Why Spolytech Co., Ltd. (KOSDAQ:050760) Should Be In Your Dividend PortfolioIs Spolytech Co., Ltd. ( KOSDAQ:050760 ) a good dividend stock? How can we tell? Dividend paying companies with growing...
분석 기사 • Jan 14Did You Participate In Any Of Spolytech's (KOSDAQ:050760) Fantastic 298% Return ?While Spolytech Co., Ltd. ( KOSDAQ:050760 ) shareholders are probably generally happy, the stock hasn't had...
Is New 90 Day High Low • Jan 13New 90-day low: ₩5,430The company is down 30% from its price of ₩7,750 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 34% over the same period.
분석 기사 • Dec 24Spolytech Co., Ltd. (KOSDAQ:050760) Passed Our Checks, And It's About To Pay A ₩50.00 DividendSpolytech Co., Ltd. ( KOSDAQ:050760 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
분석 기사 • Dec 23Is Spolytech (KOSDAQ:050760) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 14th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.9% is below the top quartile of South Korean dividend payers (2.6%), but is in line with industry peers (0.9%).
Is New 90 Day High Low • Dec 21New 90-day low: ₩5,740The company is down 22% from its price of ₩7,380 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
분석 기사 • Dec 02Is Weakness In Spolytech Co., Ltd. (KOSDAQ:050760) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Spolytech (KOSDAQ:050760) has had a rough three months with its share price down 23%. But if you pay close attention...
Is New 90 Day High Low • Nov 24New 90-day low: ₩6,420The company is down 14% from its price of ₩7,430 on 27 August 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.